Maspin acts as an inhibitor of metastasis in prostate, liver and breast cancers, in which it has been proven that nuclear IKKα, by directly binding to the Maspin promoter, represses its transcription, thereby encouraging metastasis [24, 26, 65]. Here, SERPINB5 is linked to breast carcinoma.